Cost-effectiveness analysis of amivantamab plus chemotherapy versus chemotherapy alone in NSCLC with EGFR Exon 20 insertions

Overview of attention for article published in Frontiers in oncology, March 2024

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (55th percentile)
High Attention Score compared to outputs of the same age and source (85th percentile)

Mentioned by

twitter: 3 X users

reddit: 1 Redditor

Readers on

mendeley: 4 Mendeley

Summary X Reddit

So far, Altmetric has seen 1 Reddit thread.

Cost-effectiveness analysis of amivantamab plus chemotherapy versus chemotherapy alone in NSCLC with EGFR Exon 20 insertions

User montaukwhaler, in the non small cell lung cancer subreddit, 22 Mar 2024

This page shows the most recent Reddit threads that mention this research output.

Click here to find out how to access more activity.